Qiagen
Qiagen, Eli Lilly Collaborate on Alzheimer's Risk Dx Panel
The firms will develop a multiplex PCR panel for the QiaStat-Dx system that detects APOE genotypes.
Qiagen, AstraZeneca Expand CDx Collaboration Beyond Cancer
Under the agreement, Qiagen will develop and validate a genotyping assay using its QiaStat-Dx platform.
Qiagen, Myriad Genetics to Develop Sequencing-Based Homologous Recombination Deficiency Kit
Qiagen will develop and distribute a next-generation sequencing kit-based HRD test outside the US based on Myriad's MyChoice CDx biomarkers.
The firm is offering molecular diagnostic testing and clinical trial services to bridge knowledge gaps and increase access to personalized care locally.
Qiagen, Myriad Genetics Partner to Develop Cancer Companion Diagnostics
The companies will work with pharmaceutical partners initially to develop assays using next-gen sequencing or Qiagen's Qiacuity digital PCR platform.